Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammation Associated With Cataract Surgery”

Showing 5 of 0 results

Post-approval studies (Phase 4)Study completedNCT01310127
What this trial is testing

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Who this might be right for
InflammationPseudophakia
Toyos Clinic 23
Large-scale testing (Phase 3)Study completedNCT02006888
What this trial is testing

The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

Who this might be right for
InflammationCataracts
ICON Bioscience Inc 394
Large-scale testing (Phase 3)Study completedNCT03499873
What this trial is testing

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

Who this might be right for
Cataract
Actavis Inc. 448
Large-scale testing (Phase 3)Study completedNCT02547623
What this trial is testing

Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery

Who this might be right for
Cataract
ICON Bioscience Inc 194
Not applicableStudy completedNCT01847638
What this trial is testing

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery

Who this might be right for
CataractRetinal EdemaInflammation
Melissa Toyos 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation